Penn Medicine Abramson Cancer Center


 

ASH 2019 MPN Review: Anti-thrombotic Therapy & Ropeginterferon in PV; Second Cancer in Ph- MPN; Fedratinib and Luspatercept in MF

12 views
February 24, 2020
0 Comments
Login to view comments. Click here to Login